Appropriateness of colonoscopy in Europe (EPAGE II) – Functional bowel disorders: pain, constipation and bloating

Background and study aims: To summarize the published literature on assessment of appropriateness of colonoscopy for the investigation of functional bowel symptoms, and report appropriateness criteria developed by an expert panel, the 2008 European Panel on the Appropriateness of Gastrointestinal Endoscopy, EPAGE II.

Methods: A systematic search of guidelines, systematic reviews and primary studies regarding the evaluation and management of functional bowel symptoms was performed. The RAND/UCLA Appropriateness Method was applied to develop appropriateness criteria for colonoscopy for these conditions.

Results: Much of the evidence for use of colonoscopy in evaluation of chronic abdominal pain, and/or constipation and/or abdominal bloating is modest. Major limitations include small numbers of patients and lack of adequate characterization of these patients. Large community-based follow-up studies are needed to enable better definition of the natural history of patients with functional bowel disorders. Guidelines stress that alarm features (”red flags”), such as rectal bleeding, anemia, weight loss, nocturnal symptoms, family history of colon cancer, age of onset > 50 years, and recent onset of symptoms should all lead to careful evaluation before a diagnosis of functional bowel disorder is made. EPAGE II assessed these symptoms by means of 12 clinical scenarios, rating colonoscopy as appropriate, uncertain and inappropriate in 42 % (5/12), 25 % (3/12), and 33 % (4/12) of these, respectively.

Conclusions: Evidence to support the use of colonoscopy in the evaluation of patients with functional bowel disorders and no alarm features is lacking. These patients have no increased risk of colon cancer and thus advice on screening for this is not different from that for the general population. EPAGE II criteria, available online (http://www.epage.ch), consider colonoscopy appropriate in patients of > 50 years with chronic or new-onset bowel disturbances, but not in patients with isolated chronic abdominal pain.

References

• 1 Drossman D A. The functional gastrointestinal disorders and the Rome II process.  Gut. 1999;  45 Suppl 2 II1-II5
• 2 Drossman D A. The functional gastrointestinal disorders and the Rome III process.  Gastroenterology. 2006;  130 1377-1390
• 3 Lewis S J, Heaton K W. Stool form scale as a useful guide to intestinal transit time.  Scand J Gastroenterol. 1997;  32 920-924
• 4 Manning A P, Thompson W G, Heaton K W, Morris A F. Towards positive diagnosis of the irritable bowel.  Br Med J. 1978;  2 653-654
• 5 Tougas G. The nature of pain in irritable bowel syndrome.  J Clin Gastroenterol. 2002;  35 S26-S30
• 6 Garrigues V, Galvez C, Ortiz V. et al . Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain.  Am J Epidemiol. 2004;  159 520-526
• 7 Higgins P D, Johanson J F. Epidemiology of constipation in North America: a systematic review.  Am J Gastroenterol. 2004;  99 750-759
• 8 Pare P, Ferrazzi S, Thompson W G. et al . An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking.  Am J Gastroenterol. 2001;  96 3130-3137
• 9 Sandler R S, Stewart W F, Liberman J N. et al . Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact.  Dig Dis Sci. 2000;  45 1166-1171
• 10 Hungin A P, Whorwell P J, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects.  Aliment Pharmacol Ther. 2003;  17 643-650
• 11 Mueller-Lissner S A, Bollani S, Brummer R J. et al . Epidemiological aspects of irritable bowel syndrome in Europe and North America.  Digestion. 2001;  64 200-204
• 12 Saito Y A, Schoenfeld P, Locke G R. The epidemiology of irritable bowel syndrome in North America: a systematic review.  Am J Gastroenterol. 2002;  97 1910-1915
• 13 Thompson W G, Heaton K W, Smyth G T, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral.  Gut. 2000;  46 78-82
• 14 Agrawal A, Whorwell P J. Review article: abdominal bloating and distension in functional gastrointestinal disorders – epidemiology and exploration of possible mechanisms.  Aliment Pharmacol Ther. 2008;  27 2-10
• 15 Kalloo A N. Overview of differential diagnoses of abdominal pain.  Gastrointest Endosc. 2002;  56 S255-S257
• 16 Leung F W. Etiologic factors of chronic constipation: review of the scientific evidence.  Dig Dis Sci. 2007;  52 313-316
• 17 Locke III G R, Pemberton J H, Phillips S F. American Gastroenterological Association technical review on constipation.  Gastroenterology. 2000;  119 1766-1778
• 18 Bond J H. Is referral for colonoscopy underutilized by primary care physicians?.  Gastrointest Endosc. 2000;  52 693-696
• 19 Vader J P, Pache I, Froehlich F. et al . Overuse and underuse of colonoscopy in a European primary care setting.  Gastrointest Endosc. 2000;  52 593-599
• 20 Juillerat P, Peytremann-Bridevaux I, Vader J P. et al . Appropriateness of colonoscopy in Europe (EPAGE II). Presentation of methodology, general results, and analysis of complications.  Endoscopy. 2008;  41
• 21 DeBosset V, Gonvers J J, Vader J P. et al . Appropriateness of colonoscopy: lower abdominal pain or constipation.  Endoscopy. 1999;  31 637 640
• 22 Brandt L J, Prather C M, Quigley E M. et al . Systematic review on the management of chronic constipation in North America.  Am J Gastroenterol. 2005;  100 Suppl 1 S5-S21
• 23 Longstreth G F, Thompson W G, Chey W D. et al . Functional bowel disorders.  Gastroenterology. 2006;  130 1480-1491
• 24 Piche T, Dapoigny M, Bouteloup C. et al . Recommandations pour la pratique clinique dans la prise en charge et le traitement de la constipation chronique de l’adulte.  Gastroenterol Clin Biol. 2007;  31 125-135
• 25 Sowerby Centre for Health Informatics .Constipation in adults. Newcastle, UK; SCHIN 2005
• 26 Adler A, Roll S, Marowski B. et al . Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1).  Dis Colon Rectum. 2007;  50 1628-1638
• 27 DeBosset V, Froehlich F, Rey J P. et al . Do explicit appropriateness criteria enhance the diagnostic yield of colonoscopy?.  Endoscopy. 2002;  34 360-368
• 28 Duncan J E, Sweeney W B, Trudel J L. et al . Colonoscopy in the elderly: low risk, low yield in asymptomatic patients.  Dis Colon Rectum. 2006;  49 646-651
• 29 Gonvers J J, Harris J K, Wietlisbach V. et al . A European view of diagnostic yield and appropriateness of colonoscopy.  Hepatogastroenterology. 2007;  54 729-735
• 30 Lasson A, Kilander A, Stotzer P O. Diagnostic yield of colonoscopy based on symptoms.  Scand J Gastroenterol. 2007;  1-7
• 31 Lieberman D A, de Garmo P L, Fleischer D E. et al . Colonic neoplasia in patients with nonspecific GI symptoms.  Gastrointest Endosc. 2000;  51 647-651
• 32 Morini S, Hassan C, Meucci G. et al . Diagnostic yield of open access colonoscopy according to appropriateness.  Gastrointest Endosc. 2001;  54 175-179
• 33 Pepin C, Ladabaum U. The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center.  Gastrointest Endosc. 2002;  56 325-332
• 34 Froehlich F, Gonvers J J. Diagnostic yield of colonoscopy by indication. In: Waye JD, Rex DK, Williams CB, eds Colonoscopy: principles and practice. Malden, Massachusetts, USA; Blackwell Publishing 2003: 111-130
• 35 Agence Nationale d’Accréditation et d’Evaluation en Santé .Endoscopie digestive basse: indications en dehors du dépistage en population – Argumentaire. Saint-Denis La Plaine; Haute Autorité de Santé 2004
• 36 Australian Cancer Network Colorectal Cancer Guidelines Revision Committee .Guidelines for the prevention, early detection and management of colorectal cancer. Sydney; The Cancer Council Australia and Australian Cancer Network 2005
• 37 Bleser S D. Practical symptom-based evaluation of chronic constipation.  J Fam Pract. 2006;  55 580-584
• 38 Brandt L J, Bjorkman D, Fennerty M B. et al . Systematic review on the management of irritable bowel syndrome in North America.  Am J Gastroenterol. 2002;  97 S7-S26
• 39 Camilleri M, Heading R C, Thompson W G. Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome.  Aliment Pharmacol Ther. 2002;  16 1407-1430
• 40 Drossman D A, Camilleri M, Mayer E A, Whitehead W E. American Gastroenterological Association technical review on irritable bowel syndrome.  Gastroenterology. 2002;  123 2108-2131
• 41 Fass R, Longstreth G F, Pimentel M. et al . Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome.  Arch Intern Med. 2001;  161 2081-2088
• 42 Horwitz B J, Fisher R S. The irritable bowel syndrome.  N Engl J Med. 2001;  344 1846-1850
• 43 Houghton L A, Whorwell P J. Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders.  Neurogastroenterol Motil. 2005;  17 500-511
• 44 Jones J, Boorman J, Cann P. et al . British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.  Gut. 2000;  47 Suppl 2 ii1-19
• 45 Qureshi W, Adler D G, Davila R E. et al . ASGE guideline: guideline on the use of endoscopy in the management of constipation.  Gastrointest Endosc. 2005;  62 199-201
• 46 Rao S S, Ozturk R, Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review.  Am J Gastroenterol. 2005;  100 1605-1615
• 47 Singapore Ministry of Health .Colorectal cancer. Singapore 2004: 98p
• 48 Spiller R, Aziz Q, Creed F. et al . Guidelines for the management of irritable bowel syndrome.  Gut. 2007;  56 1770-1798
• 49 Talley N J. Irritable bowel syndrome.  Intern Med J. 2006;  36 724-728
• 50 World Gastroenterology Organization .Constipation. 2007
• 51 Chan A O, Hui W M, Leung G. et al . Patients with functional constipation do not have increased prevalence of colorectal cancer precursors.  Gut. 2007;  56 451-452
• 52 Dorval E, Jankowski J M, Barbieux J P. et al . Polyethylene glycol and prevalence of colorectal adenomas.  Gastroenterol Clin Biol. 2006;  30 1196-1199
• 53 Dukas L, Willett W C, Colditz G A. et al . Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women.  Am J Epidemiol. 2000;  151 958-964
• 54 Ghadirian P, Maisonneuve P, Perret C. et al . Epidemiology of sociodemographic characteristics, lifestyle, medical history, and colon cancer: a case–control study among French Canadians in Montreal.  Cancer Detect Prev. 1998;  22 396-404
• 55 Jacobs E J, White E. Constipation, laxative use, and colon cancer among middle-aged adults.  Epidemiology. 1998;  9 385-391
• 56 Kojima M, Wakai K, Tokudome S. et al . Bowel movement frequency and risk of colorectal cancer in a large cohort study of Japanese men and women.  Br J Cancer. 2004;  90 1397-1401
• 57 LeMarchand L, Wilkens L R, Kolonel L N. et al . Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer.  Cancer Res. 1997;  57 4787-4794
• 58 Otani T, Iwasaki M, Inoue M. et al . Bowel movement, state of stool, and subsequent risk for colorectal cancer: the Japan public health center-based prospective study.  Ann Epidemiol. 2006;  16 888-894
• 59 Roberts M C, Millikan R C, Galanko J A. et al . Constipation, laxative use, and colon cancer in a North Carolina population.  Am J Gastroenterol. 2003;  98 857-864
• 60 Sonnenberg A, Muller A D. Constipation and cathartics as risk factors of colorectal cancer: a meta-analysis.  Pharmacology. 1993;  47 Suppl 1 224-233
• 61 Watanabe T, Nakaya N, Kurashima K. et al . Constipation, laxative use and risk of colorectal cancer: The Miyagi Cohort Study.  Eur J Cancer. 2004;  40 2109-2115
• 62 American Cancer Society .Cancer facts and figures 2007. 56p. http://www.cancer.org
• 63 Davila R E, Rajan E, Adler D. et al . ASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer.  Gastrointest Endosc. 2005;  61 1-7
• 64 Davila R E, Rajan E, Baron T H. et al . ASGE guideline: colorectal cancer screening and surveillance.  Gastrointest Endosc. 2006;  63 546-557
• 65 Institute for Clinical Systems Improvement .Colorectal cancer screening. Bloomington, Minnesota 2006: 51p
• 66 Levin B, Barthel J S, Burt R W. et al .Practice guidelines in Oncology: Colorectal cancer screening. National Comprehensive Cancer Network 2007
• 67 McLeod R. and the CTFPHC .Screening strategies for colorectal cancer: systematic review and recommendations. Technical review. London, Ontario; Canadian Task Force on Preventive Health Care (CTFPHC) 2001
• 68 National Guideline Clearinghouse .Colorectal cancer screening clinical practice guideline – NGC summary. Oakland (USA); Kaiser Permanente Care Management Institute 2006
• 69 Pignone M P, Rich M, Teutsch S. et al .Screening for colorectal cancer in adults. Rockville; Agency for Healthcare Research and Quality (AHRQ) 2002
• 70 Rex D K, Johnson D A, Lieberman D A. et al . Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology.  Am J Gastroenterol. 2000;  95 868-877
• 71 Winawer S, Fletcher R, Rex D. et al . Colorectal cancer screening and surveillance: clinical guidelines and rationale – Update based on new evidence.  Gastroenterology. 2003;  124 544-560
• 72 Ternent C A, Bastawrous A L, Morin N A. et al . Practice parameters for the evaluation and management of constipation.  Dis Colon Rectum. 2007;  50 2013-2022
• 73 American College of Gastroenterology . An evidence-based approach to the management of chronic constipation in North America.  Am J Gastroenterol. 2005;  100 Suppl 1 S1-S4
• 74 Thompson W G, Longstreth G F, Drossman D A. et al . Functional bowel disorders and functional abdominal pain.  Gut. 1999;  45 Suppl 2 II43-II47

1 See Appendix: The EPAGE II Study Group